TAMOXIFENO 20MG 30COM SANDOZ

Ref: 225436

Cód. de barras: 7897595601834

Princ. Ativo: NOLVADEX

Informações do produto

TAMOXIFENO 20MG 30COM SANDOZ


O citrato de tamoxifeno é indicado para o tratamento do câncer de mama. O uso contínuo de citrato de tamoxifeno inibe o crescimento do câncer de mama. Esses benefícios parecem ser independentes da idade, da fase da menopausa e da dose do medicamento.


Este medicamento não deve ser usado em casos de alergia ao citrato de tamoxifeno ou a qualquer um dos componentes do medicamento. É contraindicado em casos de gravidez, se estiver tentando engravidar ou amamentando.

Aproveite para comprar

Cód. de barras: 7897595602114

Ref: 215473

Cód. de barras: 7897595602473

Ref: 976083

Cód. de barras: 7897595620415

Ref: 1025759

Cód. de barras: 7897595631510

Ref: 10000796

Cód. de barras: 7897595606259

Ref: 1002929

Cód. de barras: 7897595625328

Ref: 10000991

Cód. de barras: 7897595602626

Ref: 1005928

Cód. de barras: 7897595631770

Ref: 535117

Cód. de barras: 7897595631527

Ref: 10000797

Cód. de barras: 7897595602206

Ref: 217840

Cód. de barras: 7897595604651

Ref: 585998

Cód. de barras: 7897595605030

Ref: 1007289

Cód. de barras: 7897595621177

Ref: 10002342

Cód. de barras: 7897595633361

Ref: 10001525

Cód. de barras: 7897595605900

Ref: 10000988

Cód. de barras: 7897595618610

Ref: 1007580

Cód. de barras: 7897595635198

Ref: 10002729

Cód. de barras: 7897595631817

Ref: 282901

Cód. de barras: 7897595609892

Ref: 259250

Cód. de barras: 7897595602510

Ref: 641499

Cód. de barras: 7897595609854

Ref: 810002

Cód. de barras: 7897595620279

Ref: 10001069

Cód. de barras: 7897595618573

Ref: 10000114

Cód. de barras: 7897595639134

Ref: 10003559

Cód. de barras: 7897595637505

Ref: 10004349

Cód. de barras: 7897595637512

Ref: 10004350

Cód. de barras: 7897595620620

Ref: 10004457

Cód. de barras: 7897595625304

Ref: 10000990

Marcas Parceiras

Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Logo

Aguarde...

Aguarde...
Recalculando valores!